Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 11:44 am Purchase | 2023-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Montanova Capital, LLC | 5,837,126 9.500% | 2,388,851 (+69.28%) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | FMR LLC | 2,990,402 4.839% | -2,127,648 (-41.57%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | BlackRock Inc. BLK | 3,408,978 5.500% | 3,408,978 (New Position) | Filing History |
| 2024-01-25 4:09 pm Purchase | 2024-01-18 | 13G | TERNS PHARMACEUTICALS INC TERN | Integrated Core Strategies (US) LLC | 3,479,630 5.600% | 3,479,630 (New Position) | Filing History |
| 2023-10-13 3:58 pm Sale | 2023-10-09 | 13G | TERNS PHARMACEUTICALS INC TERN | FMR LLC | 5,118,050 8.380% | -2,260,591 (-30.64%) | Filing History |
| 2023-10-10 09:09 am Purchase | 2023-10-09 | 13G | TERNS PHARMACEUTICALS INC TERN | FIL Ltd | 5,118,050 8.380% | 5,118,050 (New Position) | Filing History |
| 2023-10-04 5:09 pm Sale | 2023-10-04 | 13G | TERNS PHARMACEUTICALS INC TERN | Deerfield Mgmt, L.P. | 0 0.000% | -2,851,287 (Position Closed) | Filing History |
| 2023-07-28 4:25 pm Purchase | 2023-07-20 | 13G | TERNS PHARMACEUTICALS INC TERN | Deep Track Capital, LP | 3,560,000 6.280% | 3,560,000 (New Position) | Filing History |
| 2023-06-27 4:32 pm Purchase | 2023-06-20 | 13G | TERNS PHARMACEUTICALS INC TERN | Integrated Core Strategies (US) LLC | 2,313,370 4.100% | 2,313,370 (New Position) | Filing History |
| 2023-03-29 5:24 pm Unchanged | 2023-03-27 | 13D | TERNS PHARMACEUTICALS INC TERN | ORBIMED ADVISORS LLC | 7,619,135 13.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Venrock Healthcare Capital Partners III, L.P. | 3,707,891 7.700% | 641,650 (+20.93%) | Filing History |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Fairmount Funds Management LLC | 5,269,287 9.900% | 3,219,287 (+157.04%) | Filing History |
| 2023-02-13 5:57 pm Purchase | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Vivo Capital VIII, LLC | 4,340,212 9.000% | 2,022,432 (+87.26%) | Filing History |
| 2023-02-13 06:40 am Unchanged | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Auspice Ltd | 941,206 1.960% | 0 (Unchanged) | Filing History |
| 2023-02-10 3:57 pm Unchanged | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Deerfield Mgmt, L.P. | 2,851,287 5.760% | 0 (Unchanged) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | TERNS PHARMACEUTICALS INC TERN | FMR LLC | 7,378,641 14.901% | 1,736,567 (+30.78%) | Filing History |
| 2023-02-09 06:15 am Sale | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Auspice Ltd | 941,206 1.960% | -470,000 (-33.30%) | Filing History |
| 2023-02-08 5:24 pm Unchanged | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:23 pm Sale | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | -1,764,274 (Position Closed) | Filing History |
| 2023-02-06 2:45 pm Sale | 2022-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | LAV Biosciences Fund V L.P. | 2,901,566 6.100% | -63,304 (-2.14%) | Filing History |